Catalyst Wire Dossier Catalyst Wire Dossier

PRO-122 ophthalmic solution

· Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-122 ophthalmic solution, covering 2019-12-09 to 2019-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) [Phase 3]

See pricing